BSEIndrayani Biotech LtdHighNegative
Announced Wed, 27 May · 15:56 IST

Resignation letter of Mr. Indirakumar

Kmp ResignedDirector Flagged GovernanceManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+8.1%1-day move
₹10.27
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+8.1+12.9+10.2+10.0+12.0+16.1+5.6-9.9
Up moveDown movePending
AI summary

Mr. S. Indirakumar, Whole-Time Director and promoter-shareholder holding over 10.7% stake, has resigned from Indrayani Biotech Ltd effective March 16, 2026. The resignation is not voluntary, according to Indirakumar, who claims it is forced due to persistent governance failures, statutory non-compliance, and personal legal exposure. He alleges the company violated Board meeting procedures, routed supply chain operations through an undisclosed related party (HSL Agri Solutions Ltd), failed to pay dividends since the 2018 merger, and faces an Income Tax demand of Rs. 13.29 Crore. He also claims the company has not filed GST returns or deposited TDS/ESI/PF despite deducting these amounts. Indirakumar demands complete relief from all liabilities including criminal exposure and reserves the right to approach NCLT, ROC, and other regulatory bodies.

Likely market impact

This is a serious red flag for shareholders. The resignation by a promoter-shareholder citing governance collapse, statutory violations, and Rs. 13.29 crore income tax demand indicates significant operational and compliance risks. The company's stock may face selling pressure as institutional and retail investors reassess governance and legal risks. Pending regulatory actions could materially impact the company's financial health.